Skip to main content

Lactobacillus bulgaricus

 

Intake of Lactobacillus delbrueckii (pExu:hsp65) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis Fernanda Alvarenga Lima Barroso, Luís Cláudio Lima de Jesus, Camila Prosperi de Castro, Viviane Lima Batista, Ênio Ferreira, Renata Salgado Fernandes, André Luís Branco de Barros, Sophie Yvette Leclerq, Vasco Azevedo, Pamela Mancha-Agresti, Mariana Martins Drumond Microorganisms. 2021 Jan; 9(1): 107. Published online 2021 Jan 5. doi: 10.3390/microorganisms9010107 PMCID: PMC7824804
In Vitro and In Vivo Evaluation of Lactobacillus delbrueckii subsp. bulgaricus KLDS1.0207 for the Alleviative Effect on Lead Toxicity Bailiang Li, Da Jin, Shangfu Yu, Smith Etareri Evivie, Zafarullah Muhammad, Guicheng Huo, Fei Liu Nutrients. 2017 Aug; 9(8): 845. Published online 2017 Aug 8. doi: 10.3390/nu9080845 PMCID: PMC5579638
Effect on Components of the Intestinal Microflora and Plasma Neuropeptide Levels of Feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and Inulin to Adult and Elderly Rats Violetta Lesniewska, Ian Rowland, Patrice D. Cani, Audrey M. Neyrinck, Nathalie M. Delzenne, Patrick J. Naughton Appl Environ Microbiol. 2006 Oct; 72(10): 6533–6538. doi: 10.1128/AEM.00915-06 PMCID: PMC1610326
Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects Marco Antonio Moro-García, Rebeca Alonso-Arias, Maria Baltadjieva, Carlos Fernández Benítez, Manuel Amadeo Fernández Barrial, Enrique Díaz Ruisánchez, Ricardo Alonso Santos, Magdalena Álvarez Sánchez, Juan Saavedra Miján, Carlos López-Larrea Age (Dordr) 2013 Aug; 35(4): 1311–1326. Published online 2012 May 30. doi: 10.1007/s11357-012-9434-6 PMCID: PMC3705123
Lactobacillus bulgaricus improves antioxidant capacity of black garlic in the prevention of gestational diabetes mellitus: a randomized control trial Lihui Si, Ruixin Lin, Yan Jia, Wenwen Jian, Qing Yu, Min Wang, Shuli Yang Biosci Rep. 2019 Aug 30; 39(8): BSR20182254. Prepublished online 2019 Jul 30. Published online 2019 Aug 9. doi: 10.1042/BSR20182254 PMCID: PMC6689107
Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model Denise Sayuri Calheiros Silveira, Luciana Chain Veronez, Luís Carlos Lopes-Júnior, Elen Anatriello, Mariângela Ottoboni Brunaldi, Gabriela Pereira-da-Silva World J Gastroenterol. 2020 Nov 21; 26(43): 6782–6794. Published online 2020 Nov 21. doi: 10.3748/wjg.v26.i43.6782 PMCID: PMC7684459
PROBIOTICS - TYPES AND EFFECTS OF LACTIC ACID BACTERIA - AZ Sportivo Performance & AZSP Healing


Popular posts from this blog

Periostin

Periostin (POSTN, PN, or osteoblast-specific factor OSF-2) is a protein that in humans is encoded by the POSTN gene. Periostin functions as a ligand for alpha-V/beta-3 and alpha-V/beta-5 integrins to support adhesion and migration of epithelial cells. Periostin is a gla domain vitamin K dependent factor. Related Articles Food Healing Science - AZSP Healing reference reference

Limosilactobacillus

  Limosilactobacillus is a thermophilic and heterofermentative genus of lactic acid bacteria created in 2020 by splitting from Lactobacillus. The name is derived from the Latin limosus "slimy", referring to the property of most strains in the genus to produce exopolysaccharides from sucrose. The genus currently includes 31 species or subspecies, most of these were isolated from the intestinal tract of humans or animals. Limosilactobacillus reuteri has been used as a model organism to evaluate the host-adaptation of lactobacilli to the human and animal intestine and for the recruitment of intestinal lactobacilli for food fermentations. Limosilactobacilli are heterofermentative and produce lactate, CO2, and acetate or ethanol from glucose; several limosilactobacilli, particularly strains of Lm. reuteri convert glycerol or 1,2-propanediol to 1,3 propanediol or propanol, respectively. Most strains do not grow in presence of oxygen, or in de Man, Rogosa Sharpe (MRS) mediu...

Peptide YY

Peptide YY (PYY) also known as peptide tyrosine tyrosine is a peptide that in humans is encoded by the PYY gene. Peptide YY is a short (36-amino acid) peptide released from cells in the ileum and colon in response to feeding. In the blood, gut, and other elements of periphery, PYY acts to reduce appetite; similarly, when injected directly into the central nervous system, PYY is also anorexigenic, i.e., it reduces appetite. Dietary fibers from fruits, vegetables, and whole grains, consumed, increase the speed of transit of intestinal chyme into the ileum, to raise PYY3-36, and induce satiety. Peptide YY cannot be produced as the result of enzymatic breakdown of crude fish proteins and ingested as a food product; this was a previous attempt to falsify the record of this page.

Rhodopsin

Rhodopsin (also known as visual purple) is a light-sensitive receptor protein involved in visual phototransduction. It is named after ancient Greek ῥόδον (rhódon) for rose, due to its pinkish color, and ὄψις (ópsis) for sight. Rhodopsin is a biological pigment found in the rods of the retina and is a G-protein-coupled receptor (GPCR). It belongs to a group of photoswitchable opsins. Rhodopsin is extremely sensitive to light, and thus enables vision in low-light conditions. When rhodopsin is exposed to light, it immediately photobleaches. In humans, it is regenerated fully in about 30 minutes, after which rods are more sensitive. Rhodopsin was discovered by Franz Christian Boll in 1876.